FDA Review Of Children’s Cough/Cold OTCs Has Broader Implications
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA addressing whether extrapolating pediatric doses from adult data is appropriate in review of children's OTC cough/cold products.
You may also be interested in...
OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study
Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers
OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study
Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers
Sure Nature Can “Kiss” ImmunaSure Ad Goodbye – NAD
Sure Nature claims its ImmunaSure dietary supplement can help "kiss your cold sores goodbye," but the National Advertising Division does not embrace the pitch